跳至主要内容
临床试验/NCT02492451
NCT02492451终止不适用

Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles

Zeynep Kamil Maternity and Pediatric Research and Training Hospital1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
118
试验地点
1
主要终点
Pregnancy Rate

研究概览

简要总结

The investigators will try to assess the effect of endometrial injury preceding the intrauterine insemination cycle on the pregnancy rates compared to cycles with luteal phase support and the control group.

详细描述

Group 1: Endometrial biopsy is performed on days 21-24 of the spontaneous menstrual cycle proceeding the intrauterine insemination (IUI) treatment cycle. Two small biopsies are obtained from anterior and posterior walls of the uterus.

Group 2: Vaginal progesterone gel is administered for luteal phase support from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy.

Goup 3: Patients are undergone intrauterine insemination (IUI) cycles stimulated with gonadotropin without any intervention.

The effect of endometrial injury and luteal phase progesterone support on the pregnancy rate in patients intrauterine insemination (IUI) cycles stimulated with gonadotropin will be compared in terms of biochemical pregnancy rate, clinical pregnancy rate and ongoing pregnancy rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients are undergone intrauterine insemination with gonadotropin stimulation
  • Bilateral patent fallopian tubes revealed by hysterosalpingography or laparoscopy
  • After semen preparation for intrauterine insemination, total progressive sperm count > 5 million

排除标准

  • endocrin or metabolic disorders,
  • uterine factor,
  • pelvic inflammatory disease,
  • women with basal follicle-stimulating hormone (FSH) level >15 IU/mL,
  • body mass index (BMI) ≥ 35 kg/m2,
  • age ≥ 40 and < 18 years,

研究组 & 干预措施

Endometrial Injury

Active Comparator

Endometrial injury in luteal phase of preceding IUI cycle

干预措施: Endometrial Injury (Other)

Luteal Phase Support

Active Comparator

Luteal phase support with progesterone (Crinone® %8 vaginal progesterone gel) in IUI cycle Vaginal progesterone gel is administered from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy.

干预措施: progesterone (Crinone® %8 vaginal progesterone gel) (Drug)

结局指标

主要结局

Pregnancy Rate

时间窗: 12 weeks

ongoing pregnancy rates

次要结局

未报告次要终点

研究者

发起方
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Selcuk Selcuk

Medical Doctor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

研究点 (1)

Loading locations...

相似试验